| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 339070-09-6 | Methyl 4-[[(E)-Hydroxyiminomethyl]Amino]-3-Methyl-Benzoate | C10H12N2O3 |
| 339070-70-1 | N-Hydroxy-N-1H-indol-5-ylimidoformamide | C9H9N3O |
| 339071-04-4 | N-Hydroxy-N-(2-methyl-1,3-benzothiazol-6-yl)imidoformamide | C9H9N3OS |
| 339071-25-9 | N-1,3-Benzothiazol-6-yl-N-hydroxyimidoformamide | C8H7N3OS |
| 339072-10-5 | N-Acetyl-D-Glutamic Acid | C7H11NO5 |
| 339072-96-7 | (1-Oxyl-2,2,3,5,5-pentamethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate | C11H20NO3S2 |
| 339080-76-1 | Piperidine-2,2,3,3,4,4,5,5,6,6-d10 hydrochloride | C5HD10N.HCl |
| 339080-77-2 | 1,10-Decanedioic-2,2,9,9-D4 Acid | |
| 339083-80-6 | 2-Methyl-2-Propanyl (2E)-2-(4-Oxo-2-Pentanylidene)Hydrazinecarboxylate | C10H18N2O3 |
| 339086-56-5 | 3,5,9,11-Tetraazatetracyclo[5.5.2.02,6.08,12]Tetradeca-1,3,5,7,9,11-Hexaene | C10H6N4 |
| 339091-66-6 | Norepinephrine L-Bitartrate Hydrate | |
| 339091-75-7 | 1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid tetrahydrochloride hydrate | |
| 339100-95-7 | 1-(2-Chloropyridin-3-Yl)-3,3-Dimethylazetidin-2-One | |
| 339101-25-6 | Methyl 4-[2-Nitro-4-(Trifluoromethyl)Anilino]Butanoate | C12H13F3N2O4 |
| 339105-41-8 | 2-Methyl-2-Propanyl (4-Fluorophenyl)(Methylsulfonyl)Carbamate | C12H16FNO4S |
| 339105-87-2 | 3-[(3-Methylbenzyl)Sulfonyl]-1H-1,2,4-Triazole | C10H11N3O2S |
| 339151-88-1 | 2-Chloro-4,6-dimethyl-3-pyridinecarboxylic acid methyl ester | C9H10ClNO2 |
| 339155-02-1 | [2,2'-Bipyridin]-4-Yl-Phenyl-Methanone | |
| 339155-13-4 | 2,3-Pyridinedicarboxylic acid | C7H5NO4 |
| 339155-58-7 | Efalizumab | |
| 339160-37-1 | 2-Chloro-1H-Benzimidazole-5,6-Diamine | C7H7ClN4 |
| 339177-26-3 | Panitumumab | |
| 339181-24-7 | N-[3,5-Bis(Trifluoromethyl)Phenyl]-2-(Isobutylsulfanyl)Isonicotinamide | C18H16F6N2OS |
| 339181-51-0 | N-(2-Amino-1H-Imidazol-1-Yl)Glycine | C5H8N4O2 |
| 339181-52-1 | 4-{[(Z)-Triazanylidenemethyl]Amino}Butanoic Acid | C5H12N4O2 |
| 339181-64-5 | (2E)-(4,5-Dihydro-1H-Imidazol-2-Ylhydrazono)Acetic Acid | C5H8N4O2 |
| 339182-26-2 | 5-(Aminomethyl)-2-Piperidinone | C6H12N2O |
| 339182-30-8 | N-[(1-Methylhydrazino)Carbonothioyl]Glycine | C4H9N3O2S |
| 339183-92-5 | (2R,4R)-rel-N-tert-Butyloxycarbonyl-4-methyl-2-piperidinecarboxylic Acid Benzyl Ester | C19H27NO4 |
| 339184-87-1 | 1,4-Dioxaspiro[4.4]Non-6-Ylmethyl Acetate | C10H16O4 |
| 339185-69-2 | 2-Methyl-2-Propanyl [2-(3-Bromophenyl)-2-Oxoethyl]Carbamate | C13H16BrNO3 |
| 339186-28-6 | {2-[(2R,3R,4R,5S)-3,4-Dihydroxy-5-Methyl-2-Pyrrolidinyl]Ethyl}Phosphonic Acid | C7H16NO5P |
| 339186-29-7 | {2-[(2R,3R,4R,5R)-3,4-Dihydroxy-5-Methyl-2-Pyrrolidinyl]Ethyl}Phosphonic Acid | C7H16NO5P |
| 339186-68-4 | Matuzumab | |
| 339190-10-2 | 1-Allyl-3-Methyl-1,3-Dihydro-2H-Imidazol-2-One | C7H10N2O |
| 339195-19-6 | [[(1,1-Dimethylethoxy)carbonyl]amino]ferrocene | C15H19FeNO2 |
| 339195-51-6 | (6-Amino-2-Pyridinyl)Acetic Acid | C7H8N2O2 |
| 339196-89-3 | 6,6-Dimethyl-5-Methylene-4-Phenyl-1,3,4-Oxadiazinan-2-One | C12H14N2O2 |
| 339197-79-4 | 2-(2,3-Dichlorophenyl)-1,3-Benzoxazol-5-Amine | C13H8Cl2N2O |
| 339207-77-1 | 2-(Benzylamino)-3-(1H-Imidazol-5-Yl)-1-Propanol | C13H17N3O |
| 339208-90-1 | (3-Chloro-Phenyl)-[(9H-Fluoren-9-Ylmethoxycarbonylamino)]-Acetic Acid | C23H18ClNO4 |
| 339208-91-2 | (4-Chloro-Phenyl)-[(9H-Fluoren-9-Ylmethoxycarbonylamino)]-Acetic Acid | C23H18ClNO4 |
| 339208-92-3 | [(9H-Fluoren-9-Ylmethoxycarbonylamino)]-Naphthalen-1-Yl-Acetic Acid | C27H21NO4 |
| 339221-70-4 | (3R,4S)-5-Ethoxy-3,4-Dihydro-2H-Pyrrole-3,4-Dicarbonitrile | C8H9N3O |
| 339235-30-2 | Ethyl 4-Oxo-1,4-Dihydrobenzo[h]Quinoline-3-Carboxylate | C16H13NO3 |
| 339261-32-4 | 2-(Dimethylamino)Propyl 2-Furoate | C10H15NO3 |
| 339264-51-6 | (3-Fluoro-4-Methoxyphenyl)Hydrazine | C7H9FN2O |
| 339267-31-1 | (5R)-5-Isopropyl-2-methylenecyclohexanol | C10H18O |
| 339268-21-2 | Potassium Hexakis(Cyano-kappac)Ruthenate(4-) Hydrate (4:1:1) | C6H2K4N6ORu |
| 339274-33-8 | (S)-Amino-o-Tolyl-Acetic Acid | C9H11NO2 |